Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-26-001581
Filing Date
2026-03-23
Accepted
2026-03-23 07:09:07
Documents
111
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2634707.htm   iXBRL 20-F 3497494
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 186035
3 EXHIBIT 2.2 exhibit_2-2.htm EX-2.2 51736
4 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 4074
5 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 13422
6 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 12980
7 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4471
8 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 4459
9 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 3124
15 GRAPHIC image0.jpg GRAPHIC 38360
16 GRAPHIC image2.jpg GRAPHIC 204156
17 GRAPHIC image3.jpg GRAPHIC 12594
18 GRAPHIC image00001.jpg GRAPHIC 38360
  Complete submission text file 0001178913-26-001581.txt   15150465

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE blrx-20251231.xsd EX-101.SCH 136572
11 XBRL CALCULATION FILE blrx-20251231_cal.xml EX-101.CAL 74724
12 XBRL DEFINITION FILE blrx-20251231_def.xml EX-101.DEF 312608
13 XBRL LABEL FILE blrx-20251231_lab.xml EX-101.LAB 1098870
14 XBRL PRESENTATION FILE blrx-20251231_pre.xml EX-101.PRE 513661
115 EXTRACTED XBRL INSTANCE DOCUMENT zk2634707_htm.xml XML 3024776
Mailing Address 2 HAMAAYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN Israel ISRAEL
Business Address 2 HAMAAYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN Israel ISRAEL 972-8-642-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35223 | Film No.: 26779874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)